Pear Healthcare Playbook Vivien Ho, Dr. Andrew Parambath, and Lipsa Panda

Welcome back to the Pear Healthcare Playbook! Every week, we’ll be getting to know trailblazing healthcare leaders and diving into building a digital health business from 0 to 1.

Today, we're thrilled to introduce Ron Vianu, the CEO and visionary behind Covera Health. Covera Health is a pioneering AI-enabled diagnostic technology company, specializing in radiology performance measurement and its consequential impact on healthcare. With a career spanning over three decades, Ron has been a driving force at the intersection of healthcare, technology, and insurance.

Ron's entrepreneurial journey began over 30 years ago, founding his first health tech company while a senior at NYU.    His first deep exposure to the field of Radiology was with Spreemo, a company he founded with his co-founder, an orthopedic surgeon, in 2010.  Spreemo was a referral management platform in the occupational medicine space. Spreemo grew to over 200 employees across offices in New York City and Dallas and received significant investment from venture and PE investors. 

In this episode, we talk about Ron’s work with Spreemo, how he started Covera Health, the partnership with Walmart, his thoughts on the future of AI in radiology, and advice he has for founders. 

Founded in 2020, Pearl Health was incubated by AlleyCorp and has raised a total of $95M in funding from 8 investors, led by Andreesen Horowitz and Viking Global Investors. Pearl now has over 100 employees and closed a $75M Series B in January of 2023.

Pearl Health is a provider enablement and value-based care technology company that helps primary care providers and healthcare organizations succeed in value-based care, starting with ACO REACH and, soon, MSSP and Medicare Advantage.. Pearl does this by helping PCPs and their staff focus attention on high-risk patients and conditions, enabling practices with insights to programs deliver high quality, holistic care to patients at the right time. In 2024, Pearl is partnering with about 1,800 primary care providers, who collectively serve more than 80,000 patients, across the US in 43 states and Washington, D.C.

With over 20 years of experience in healthcare, Jennifer started her career at Triage Consulting Group. She then served as a consultant at Deloitte for 5 years and moved on to Takeda Oncology where she was an Associate Director in market access. She then spent six years at athenahealth where she served in a series of roles in product management, ultimately concluding as an Executive Director for product management. 

After Athena, Jennifer moved onto a VP / Head of Product role at Hint Health and finally became the Chief Product Officer at Pearl Health in 2021. Jennifer holds a BA from University of California, Berkeley and an MHA from University of North Carolina at Chapel Hill.

In this episode, we learn how Pearl Health is trying to improve primary care provider workflows in value-based care, how Jennifer thinks about product management, and where Pearl Health is going next, with their partnerships with retail pharmacies.

This week, we’re super excited to chat with Dr. Matt Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences.

At Microsoft, Dr. Lungren focuses on translating cutting-edge technology, including general AI and cloud services, into innovative healthcare applications. As a physician and clinical machine learning researcher, he maintains a part-time clinical practice at UCSF while also continuing his research and teaching roles as adjunct professor at Stanford. 

Prior to his role at Microsoft, Dr. Lungren was a clinical interventional radiologist and research faculty at Stanford Medical School where he led the Stanford Center for artificial intelligence and medicine and imaging. His scientific work has led to more than 150 publications including work on multimodal data fusion models for healthcare applications. On top of all of that, Dr. Lungren is also a top-rated instructor on Coursera with his AI and Healthcare course designed to help learners with non-technical backgrounds. 

In this episode, we talk about Matt’s clinical, academic, and private sector experiences, how technology within the radiology field has developed throughout time, and exciting new Microsoft HLS Research projects and the impact of AI research on healthcare.

Welcome back to the Pear Healthcare Playbook! Every week, we’ll be getting to know trailblazing healthcare leaders and dive into building a digital health business from 0 to 1.



Today, we're so excited to get to know Wei-Li Shao, President of Omada, a virtual care program that blends human experiences technology and behavior science to help people with chronic conditions achieve their healthy goals. With over 25 years of global healthcare experience, Wei-Li has worked in digital care, biopharmaceuticals, imaging, and diagnostics spanning many therapeutic areas. Before joining Omada, Wei-Li held prominent executive roles at Eli Lilly and Company in the USA, China, Taiwan, and New Zealand. His educational background includes dual degrees in biochemistry and molecular biology from the University of Wisconsin Madison, complemented by an MBA in marketing from the Kellogg School of Business.



In this episode, we discuss Omada Health's core operations, discuss the optimal timing for startups to bring in C-suite executives, explore Omada's journey to serving 1 million members, examine its pioneering work in the GLP-1 (Glucagon-Like Peptide-1) space, and uncover how Omada leverages AI to enhance its services.

This week, we’re super excited to chat with Brian Anderson, co-founder of CHAI, Coalition for Health AI, and Chief Digital Health Physician at MITRE.

CHAI is a community of academic health systems, organizations, and expert practitioners of artificial intelligence and data science. Brian leads research and development efforts across major strategic initiatives in digital health, partnering with the US government and private sector companies. 

Prior to joining MITRE, Anderson led the Informatics and Network Medicine Division at athenahealth, where he launched a new model of clinical decision support leveraging artificial intelligence. He has also served on several national health information technology committees in partnership with the Office of the National Coordinator (ONC). On top of all that, Brian is also a Harvard Medical School Associate Professor of Biomedical Informatics and senior advisor for ARPA-H in Clinical Trial Innovation. Anderson completed his clinical training at Massachusetts General Hospital and completed his B.A. and M.D. degrees at Harvard College and Harvard Medical School.

In this episode, we talk about Brian’s career journey from clinical practice to digital health, CHAI’s efforts to establish AI process standards for healthcare, the concept of a federated network of assurance labs, and advice for the health AI innovation community. 

Today we're thrilled to get to know Robin Shah! Robin is the founder and CEO of Thyme Care, a groundbreaking oncology management platform. Thyme Care is a value-based cancer care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals with cancer. Thyme Care's approach combines human guidance with data and analytics to guide patients through their cancer journey. The company partners with health plans and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care.



Robin's journey in transforming cancer care began at Flatiron Health, a leading healthcare technology company led by two remarkable founders Nat Turner and Zach Weinberg. There, he served as Vice President of Provider Marketing and Strategy, focusing on developing successful go-to-market strategies for both patients and healthcare providers. His passion for building a stronger future for community oncology led him to OneOncology, where he played a crucial role as a founding member. At OneOncology, Robin served as the Chief Development and Marketing Officer, overseeing provider development, marketing strategy, technology integration, and analytics, setting the stage for his work at Thyme Care.



In this episode, we discuss Robin's journey into the field of oncology, the inception of Thyme Care, the significance of care navigation in cancer, Thyme Care's strategic approach and achievements, as well as valuable advice for entrepreneurs, including guidance on choosing the right investment partners.